Margaret T. Jones
Springfield College
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Margaret T. Jones.
Medicine and Science in Sports and Exercise | 2004
Alexander P. Tuckow; Bradley C. Nindl; Clay Pandorf; M. Javad Khosravi; Anastasia Diamandi; Robert Welles; Margaret T. Jones; Michael J. Germain; Samuel Headley
OBJECTIVE To examine the hypothesis that 12 weeks of resistance training would alter circulating concentrations of IGF-I system components in end-stage renal disease (ESRD) patients. DESIGN Ten ESRD patients underwent 12 weeks of resistance training after a 6 week control period and had morning fasted blood drawn on four occasions (weeks - 6, 0, 6, 12). Immunoassays were performed for serum total and free IGF-I, IGF binding proteins (IGFBPs) 2 and 3, and the acid labile subunit (ALS). Immunoaffinity depletion of ALS-based complexes allowed measurement of non-ternary (i.e., binary) IGF-I and IGFBP-3. RESULTS Significant improvements in strength and functional performance were observed. All IGF-I measures were stable during the control period and no changes were observed for the first 6 weeks of resistance training. At week 12, total IGF-I (-15.4+/-28.9%), ternary IGF-I (-16.4+/-36.7%), and the IGF-I/IGFBP-3 ratio had significantly (p < or = 0.05) declined from week 0 values. No changes were observed for free IGF-I, IGFBPs 2 and 3, or the acid labile subunit. The proportion of IGF-I in ternary ( approximately 76.3+/-6.8%), non-ternary ( approximately 22.5+/-6.6%), and free ( approximately 1.2+/-0.5%) forms remained constant throughout the training. CONCLUSIONS 12 weeks of resistance training in ESRD patients induced a decline in total IGF-I, but did not alter the proportion of IGF-I circulating in free, ternary or non-ternary molecular complexes. The decline in IGF-I occurs in the presence of positive training adaptations on physical performance and we conclude that this response pattern appears to be reflective of favorable neuromuscular anabolic adaptations.
American Journal of Kidney Diseases | 2002
Samuel Headley; Michael J. Germain; Patrick Mailloux; Jeffrey G. Mulhern; Brian Ashworth; Jami Burris; Britton Brewer; Bradley Nindl; MaryAnn Coughlin; Robert Welles; Margaret T. Jones
Growth Hormone & Igf Research | 2004
Bradley C. Nindl; Samuel Headley; Alexander P. Tuckow; Clay Pandorf; Anastasia Diamandi; M. Javad Khosravi; Robert Welles; Margaret T. Jones; Michael J. Germain
Strength and Conditioning Journal | 1999
Douglas P. Mann; Margaret T. Jones
Archive | 1999
Anthony T Jarvis; Scott D Felix; Stacy Sims; Margaret T. Jones; Samuel Headley
Athletic Therapy Today | 1998
Margaret T. Jones; Cynthia A. Trowbridge
Athletic Therapy Today | 1998
Catherine A. Hartman; Dwight M. Hartman; Margaret T. Jones
PubliCE Premium | 2007
Anthony T Jarvis; Scott D Felix; Stacy Sims; Margaret T. Jones; Mary Ann Coughlin; Samuel Headley
PubliCE Standard | 2006
Anthony T Jarvis; Scott D Felix; Stacy Sims; Margaret T. Jones; Mary Ann Coughlin; Samuel Headley
Medicine and Science in Sports and Exercise | 2002
Samuel Headley; Michael J. Germain; P Mailloux; J Mulhern; B M. Ashworth; J L. Burris; B Brewer; Bradley C. Nindl; M Coughlin; Robert Welles; Margaret T. Jones
Collaboration
Dive into the Margaret T. Jones's collaboration.
United States Army Research Institute of Environmental Medicine
View shared research outputs